Edesa Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY	FY
Period Ending	Apr '26 Apr 24, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Aug '12 Aug 31, 2012	Aug '11 Aug 31, 2011
Market Cap	65	18	14	926	-
Market Cap Growth	315.69%	22.07%	-98.44%	-	-
Enterprise Value	52.46	16.11	13.41	925.42	0
Last Close Price	7.26	2.47	4.45	999.60	1646.40
PE Ratio	-	-1.94	-2.31	-8330.00	-18293.30
PS Ratio	-	-	-	3238.67	-
PB Ratio	12.99	1.42	7.29	1074.14	-
P/TBV Ratio	3.56	1.13	7.18	50734.94	20023.40
P/FCF Ratio	-	-2.41	-2.96	-230.10	-
P/OCF Ratio	-	-2.41	-2.96	-234.67	-
EV/Sales Ratio	-	-	-	3235.13	-
EV/EBITDA Ratio	-	-2.07	-1.96	-154.90	-
EV/EBIT Ratio	-	-2.04	-1.91	-152.05	-
EV/FCF Ratio	-	-2.20	-2.74	-229.85	-
Debt / EBITDA Ratio	-	-	0.00	-	-
Debt / FCF Ratio	-	-	0.00	-	-
Net Debt / Equity Ratio	-0.86	-0.87	-0.51	-1.17	-1.35
Net Debt / EBITDA Ratio	1.71	1.39	0.15	0.17	1.13
Net Debt / FCF Ratio	1.81	1.47	0.21	0.25	1.45
Asset Turnover	-	0	0	0.09	0.14
Quick Ratio	16.51	10.60	0.71	1.81	26.30
Current Ratio	16.82	10.67	0.91	1.86	26.53
Return on Equity (ROE)	-82.15%	-99.57%	-311.44%	-260.21%	-114.87%
Return on Assets (ROA)	-75.44%	-91.24%	-183.95%	-189.66%	-78.74%
Return on Invested Capital (ROIC)	-547.02%	-603.20%	-727.99%	-2145.31%	-838.71%
Return on Capital Employed (ROCE)	-87.78%	-109.63%	-354.07%	-214.04%	-81.45%
Earnings Yield	-12.12%	-51.42%	-43.37%	-0.01%	-0.01%
FCF Yield	-12.23%	-41.51%	-33.84%	-0.43%	-
Buyback Yield / Dilution	-110.15%	-77.54%	92.70%	-14.93%	-
Total Shareholder Return	-110.15%	-77.54%	92.70%	-14.93%	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q